FDA passes Mifeprex changes, reducing cost for abortions despite risk to women
The Food and Drug Association (FDA) changed the regimen for mifepristone (Mifeprex), significantly reducing the obstacles, burden, and cost to abortionists. The move includes approval of new labeling for the abortion More...
NC physician petitions FDA to ‘fast-track’ Tekmira’s Ebola drug
With the Ebola Virus Disease (EVD) raging through West Africa resulting in the largest outbreak of the lethal disease since first found in 1976, one North Carolina physician is petitioning the Food and Drug Administration More...
FDA grants ‘fast track designation’ to Tekmira to develop Ebola drug
Canadian pharmaceutical company, Tekmira Pharmaceuticals Corporation announced Wednesday that the US Food and Drug Administration (FDA) has granted Fast Track designation for the development of TKM-Ebola, an anti-Ebola More...